
Why Cancer Patients Still Die From Infections We Can't Diagnose - Karius
Shownotes
In this episode of Diagnosing Dx, David Filby is joined by Alec Ford, Chief Executive Officer at Karius.
Alec brings decades of leadership experience across therapeutics, vaccines, and genomics. In this conversation, we explore how Karius is bringing genomics into infectious disease and why the company has focused so sharply on immunocompromised patients.
The scale of the unmet need is staggering. Alec explains that 52% of cancer deaths in the US are due to infection rather than the underlying malignancy, rising to more than 60% in hematologic malignancies. He also shares that there are around 4 million hospital admissions for infection among cancer patients in the US each year, yet the standard hospital workup can still fail to identify the cause in far too many cases.
We also discuss the company’s growth, physician adoption, and why outpatient infectious disease testing could become a major next step.
This is a practical conversation about infectious disease diagnostics, commercialization, and building in one of the most important unmet areas in healthcare.
Key takeaways:
🔹 Why infectious disease remains one of the biggest threats to immunocompromised patients
🔹 How Karius is using microbial cell-free DNA to diagnose infection from a simple blood draw
🔹 Why focus and disciplined market selection have been central to Karius’ growth
🔹 How physician confidence and education shape adoption of new diagnostics
🔹 Why outpatient infectious disease testing could become a major next step for the field
Chapters:
01:00 Introduction and Alec Ford’s background
04:20 Transition from therapeutics to genomics
08:34 The founding story of Karius and how the technology works
14:52 Why Karius focused on immunocompromised patients
19:41 Scaling the company and driving adoption
27:20 Reimbursement, capital strategy, and path to profitability
34:40 The outpatient opportunity and Karius’ next chapter
45:03 Alec’s view on the diagnostics industry and what needs to change
Guest: Alec Ford
Chief Executive Officer at Karius
LinkedIn: https://www.linkedin.com/in/alec-ford-b578003/
Host: David Filby
Founder and CEO of Elevra Consulting
LinkedIn: https://www.linkedin.com/in/davidfilby/
Learn more about Karius here: https://kariusdx.com/
🔔 Subscribe to Diagnosing Dx for weekly conversations with leaders shaping the future of diagnostics and omics.